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BACKGROUND/PURPOSE: The early diagnosis and appropriate management of spinal tuberculosis 
(TB) is challenging for clinicians. This study aimed to characterize the clinical features and factors affecting 
treatment outcomes.
METHODS: A retrospective study of patients with spinal TB over a 7-year period at a medical center 
in southern Taiwan was conducted. Clinical features, underlying diseases, laboratory results, imaging 
findings, therapy, treatment duration and outcomes were analyzed.
RESULTS: Forty-eight patients (24 men and 24 women) were diagnosed with spinal TB. Their mean age 
was 64.3 years. The most common presenting symptoms were backache, neurological deficits, and fever. 
The most common vertebral area involved was lumbar spine (41.7%). The mean number of vertebra 
involved was 2.46. Surgery was carried out on 30 patients (62.5%). Patients who had a longer duration of 
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Introduction
Spinal tuberculosis (TB) was known in ancient Egypt. It 
was described by Hippocrates, and in 1779, Percivall Pott 
published the first modern description of spinal defor-
mity and paraplegia resulting from spinal TB.1–4 Bone and 
joint TB may account for 15–35% of patients with extra-
pulmonary TB,5,6 and for 1–5% of all cases of TB.2,6,7 
Spinal TB, also referred to as Pott’s disease, accounts for 
approximately half of patients with skeletal TB.1,2,6–8 
Spinal TB usually develops insidiously and the presence 
of fever is noted in about one-third of all cases, thus the 
diagnosis is often delayed.1,7 Pott’s paraplegia can be early or 
late onset, which is the most threatening complication.9 
The lower thoracic and the lumbar spines are the most 
commonly involved sites.1,7,10,11 Despite current diagnos-
tic imaging facilities providing more information, diag-
nosis and treatment remain challenging due to the slow 
progressive clinical features, which lead to neurological 
sequelae and spinal deformity.4 Early diagnosis and treat-
ment is the key to avoiding this long-term disability.
The optimal treatment for spinal TB remains contro-
versial, particularly the duration of chemotherapy and 
treatment modalities (chemotherapy alone or combined 
with surgical intervention).8,12–15 In an attempt to answer 
some of these questions, the Medical Research Council 
(MRC) in the United Kingdom has been carrying out ran-
domized controlled trials involving various treatment 
modalities for spinal TB in Africa and Asia.16–19 The re-
sults suggest that anti-TB therapy, rather than surgery, 
should be the standard of care, but these results may not 
be applicable to all situations.13 Despite the high efficacy 
of anti-TB therapy, some studies advocate aggressive sur-
gery for spinal TB.11,20 In the past, 12–18 months of medi-
cal treatment were advocated for skeletal TB.8,11,21,22 More 
recently, the American Thoracic Society and Centers for 
Disease Control and Prevention recommended a 6–9 month 
treatment course for adult bone and joint TB.23
Due to this controversy regarding the management of 
spinal TB, we conducted a retrospective study at a tertiary 
teaching hospital over a 7-year period. This study aimed 
to determine the risk factors for unfavorable outcomes 
and the role of different treatment periods, treatment 
modalities, and diagnostic methods on the outcomes for 
patients with spinal TB.
Methods
From January 1, 2002 to December 31, 2008, patients aged 
over 10 years with a diagnosis of spinal TB were reviewed 
at a 1,600-bed tertiary hospital in southern Taiwan. A di-
agnosis of spinal TB was made if at least one of the follow-
ing criteria were met: (1) Mycobacterium tuberculosis was 
isolated or acid-fast bacilli (AFB) was found in the speci-
men of spinal tissue, epidural, paraspinal, or psoas muscle 
abscess; (2) histopathological evidence (caseating granu-
loma or granulomatous inflammation with or without 
positive AFB smear) of TB infection from spinal tissue; 
which responded to anti-TB therapy; (3) M. tuberculosis 
was isolated from another coexisting focus of infection in 
symptoms prior to diagnosis were more likely to have surgery (p = 0.03), and patients who received surgery 
had a more favorable outcome (p = 0.063). The mean treatment course was 11.4 ± 3.7 months. A long 
course treatment did not contribute to favorable outcomes. Twenty-six patients had a favorable outcome 
and 11 had an unfavorable outcome. Factors associated with an unfavorable outcome included older age, 
limb weakness, incontinence, spinal kyphotic deformity, and spinal cord compression.
CONCLUSION: For elderly patients with chronic back pain in Taiwan, the differential diagnosis of 
spinal TB should be considered. Image studies and computed tomography-guided aspiration are helpful 
for early detection. Combined surgical intervention tended to have a more favorable outcome and longer 
treatment periods had no additional benefit.
KEYWORDS: antituberculous therapy, outcome, spine, tuberculosis
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the presence of typical clinical and radiological pictures of 
spinal TB; (4) patients with a highly probable diagnosis 
not confirmed microbiologically or histopathologically, 
but in whom the diagnosis was supported by radiological 
manifestations [X-ray, computed tomography (CT) scan, 
and magnetic resonance imaging (MRI)] or clinical fea-
tures that correlated with spinal TB and a good reaction 
to anti-TB therapy.1,13,15,24
The demographics, clinical pictures at presentation, 
underlying diseases or risk factors, methods of diagnosis, 
laboratory results and radiographic features, histological 
findings, microbiological results, modes of therapy and 
drugs used, duration of treatment, and outcome at the 
end of the follow-up period were recorded.
Definitions
Elderly persons were defined as those aged > 60 years. The 
treatment duration was classified into two groups: (1) a 
short course defined of less than 9 months; (2) a long course 
defined of more than 9 months. The outcome at the end 
of the follow-up period was classified into two groups: (1) 
favorable status: full physical activity at work, no evidence 
of central nervous system involvement, no remaining sinus 
or abscess that was clinically or radiologically detectable, 
and radiological evidence of healing of the spinal lesion; 
(2) unfavor able status: not radiographically quiescent, lim-
ited physical activity, clinically evident abscess or sinus 
present, myelopathy with functional impairment, a need 
for additional chemotherapy for spinal disease, or death 
associated with spinal disease.16 Patients with non-spinal 
TB-related deaths before treatment completion, and those 
lost to follow-up or still on treatment at the time of data 
analysis, were not enrolled in the analysis of post-treatment 
outcomes. Concomitant pulmonary TB was defined as a 
positive AFB smear, or M. tuberculosis cultured in concomi-
tant sputum when the diagnosis of spinal TB was made. 
Surgical procedures included abscess drainage or curettage, 
debridement, anterior or posterior stabilization with bone 
graft or instrumentation, anterior decompression, vertebral 
curettage, laminectomy, and discectomy.
Statistical analysis
All statistical calculations were done using the SPSS ver-
sion 15.0 (SPSS Inc., Chicago, IL, USA). Comparisons were 
made between patients with favorable and unfavorable 
outcomes. Continuous variables were compared using 
Student’s t test and a p value < 0.05 was considered statis-
tically significant. Comparisons between categorical vari-
ables were performed using χ2 or Fisher’s exact test and a 
p value < 0.05 was considered to be statistically significant. 
An odds ratio (OR) and 95% confidence interval (CI) were 
calculated to evaluate the strength of any associations, as 
well as the precision of the estimated effects.
Results
General and epidemiological data
Of the 3,888 TB patients studied over a 7-year period in 
our hospital, 701 (18.0%) had extrapulmonary TB. One-
hundred and thirty patients with bone and joint TB ac-
counted for 18.5% of extra-pulmonary TB cases and 3.3% 
of all TB cases. There were 48 patients with spinal TB, con-
stituting 1.2% of all cases of TB and 36.9% of the 130 bone 
and joint TB cases. Twenty-four patients were male, and 
24 female, with a mean age of 64.3 ± 15.5 years (range,
10–88 years). The demographics and clinical characteris-
tics of the 48 patients with spinal TB are summarized in 
Table 1. There were 21 cases that fulfilled diagnostic crite-
ria (1), 13 fulfilled criteria (2), 14 fulfilled criteria (4); no 
cases fulfilled criteria (3).
Microbiological and histological findings
Of the 48 patients, 14 (29.2%) were diagnosed based on clin-
ical features and image findings, but were not confirmed 
by histological or microbiological studies. Twenty-one pa-
tients (43.8%) were diagnosed based on microbiological 
findings (2 patients by a positive AFB smear, 11 patients 
by a positive culture of M. tuberculosis, and 8 patients by 
both positive AFB and TB culture from spine or paraspi-
nal site). Of the 21 patients with positive microbiological 
findings, 11 also had histological evidence (caseating 
granuloma). Thirteen patients (27.1%) were diagnosed 
based on histological findings alone.
Invasive diagnostic procedures were performed using 
CT-guided fine-needle aspiration or open surgical biopsy. 
Three patients did not receive invasive diagnostic proce-
dures. Not all patients who received invasive diagnostic 
procedures had all the examinations of histology, AFB 
smear, and TB culture at the same time (Table 2). CT-
guided fine-needle aspiration was performed on 27 patients. 
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The results for positive AFB smear, TB culture, and granu-
lomas were 35.0% (7/20 cases), 55.0% (11/20 cases), and 
34.8% (8/23 cases), respectively. Open surgical biopsy was 
performed on 30 patients and the yields for positive AFB 
smear, TB culture, and granulomas were 25.0% (3/12 cases), 
75.0% (9/12 cases), and 53.3% (16/30 cases), respectively. 
Twelve patients received both procedures; four had nega-
tive results for microbiology and histology. Of these four 
with negative results for the initial CT-guided fine-needle 
aspiration, the diagnosis was confirmed in two cases by 
positive granulomas; the other two had negative results 
even after open surgical biopsy. There was no significant 
difference between the yields of these two methods.
M. tuberculosis was isolated from spinal or paraspinal 
tissues in 19 patients. Eighteen isolates (94.7%) were sus-
ceptible to all of the first-line anti-TB drugs. One patient 
(5.3%) was resistant to both isoniazid and rifampin. Eleven 
patients (22.9%) had concomitant active pulmonary TB 
and one (2.1%) had genitourinary tract involvement.
Underlying diseases, clinical presentations and 
laboratory data
The demographics, clinical, laboratory and image charac-
teristics of the 48 patients with spinal TB are shown in 
Table 1. Thirty-five patients (72.9%) had comorbid dis-
eases or risk factors. Fifteen (31.3%) had chronic kidney 
disease (11 were on hemodialysis), 12 (25.0%) had diabetes 
mellitus, six (12.5%) had previous TB (4 with pulmonary, 
2 with extrapulmonary), four (8.3%) had malignancy, four 
(8.3%) had chronic lung disease, three (6.3%) were intra-
venous drug users, three (6.3%) had liver cirrhosis, two 
(4.2%) had received corticosteroids, and one (2.1%) had 
human immunodeficiency virus infection. Thirteen pa-
tients (27.1%) had no underlying disease. Twelve patients 
(25.0%) had two or more comorbid diseases.
The duration of symptoms prior to diagnosis ranged 
from 15 days to 24 months (mean ± standard deviation, 
6.91 ± 5.97 months). Forty-six patients (95.8%) had back 
pain and 37 patients (77.1%) had neurological deficits 
Table 1. Demographic and clinical data of patients with 
spinal tuberculosis (n = 48)a
Variable
Age (yr) 64.31 ± 15.46
Sex, male:female 24:24
Duration of symptoms to 
diagnosis (mo)  6.91 ± 5.97
Symptoms
 Back pain 46 (95.8)
 Neurological deficits 37 (77.1)
  Limb weakness 30 (62.5)
  Limb numbness 27 (56.3)
  Incontinence 7 (14.6)
 Fever 19 (39.6)
Laboratory finding on admission
 WBC (× 109/L) 8.019 ± 3.991
 CRP (mg/L) 55.30 ± 69.00
 ESR (mm/hr) (n = 29) 71.17 ± 32.33
Location of spinal TB 
 Cervical  2 (4.2)
 Thoracic 16 (33.3)
 Thoracolumbar 8 (16.7)
 Lumbar 20 (41.7)
 Lumbosacral 2 (4.2)
Image findings 
 Presence of abscess  37 (77.1)
 Spinal kyphotic deformity 22 (45.8)
 Collapse vertebra 33 (68.8)
 Evidence of cord compression 18 (37.5)
 Number of vertebra involved 2.46 ± 1.07
Concomitant pulmonary TB 11 (22.9)
Duration of treatment (mo) 11.38 ± 3.73
aData presented as n (%) or mean ± standard deviation. CRP = 
C-reactive protein; ESR = erythrocyte sedimentation rate; TB = tuber-
culosis; WBC = white blood cell count.
Table 2. Yield of computed tomography-guided fine-needle 
aspiration and open surgical biopsy for the diagnosis of 
spinal tuberculosis
 CT-guided Open surgical
 fine-needle biopsy pb
 aspiration (n = 27) (n = 30)
Positive AFB smear 7/20 (35.0) 3/12 (25.0) 0.70
Positive TB culture 11/20 (55.0) 9/12 (75.0) 0.45
Positive granuloma 8/23 (34.8) 16/30 (53.3) 0.29
aData presented as number of positive cases/total number of 
patients who received the examination (%); bχ2 test for categorical 
variables. CT = Computed tomography; AFB = acid-fast bacilli; TB = 
tuberculous.
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with varied severity (limb weakness, limb numbness and 
incontinence). Six patients (12.5%) had paraplegia. Only 
19 patients (39.6%) had fever and 4 (8.3%) had weight loss.
On admission, the mean serum white blood cell count 
was 8.019 ± 3.991 × 109/L (range, 3.280–30.400 × 109/L) 
and the mean C-reactive protein level was 55.3 ± 69.0 mg/L 
(range, 0.5–344.4 mg/L). The mean erythrocyte sedimen-
tation rate was 71.2 ± 32.3 mm/hr (range, 19–126 mm/hr). 
There was no significant difference in age, sex, underlying 
diseases, clinical presentations, laboratory data on admis-
sion, treatment duration, or outcomes between the three 
groups according to the diagnostic criteria.
Patients aged over 60 years had more neurological def-
icits (87.1% vs. 58.8%; OR = 4.725, 95% CI = 1.134–19.680; 
p = 0.036), and more limb weakness (74.2% vs. 41.2%; OR = 
4.107, 95% CI = 1.168–14.436; p = 0.05).
Image findings
All patients had received both plain radiography and 
spine MRI. The most common vertebral area involved was 
lumbar (20, 41.7%), followed by thoracic (16, 33.3%) and 
thoracolumbar (8, 16.7%). The mean number of vertebra 
involved was 2.46 ± 1.07 (range, 1–7). Thirty-seven pa-
tients (77.1%) had an abscess (epidural, paraspinal or psoas 
muscle sites) on MRI. Twenty-two patients (45.8%) showed 
kyphotic deformity, and vertebra collapse was found in 
33 patients (68.8%) on plain radiography or MRI of the 
spine. Spinal cord compression was found in 18 patients 
(37.5%) on MRI. Significantly, fewer cases with abscess 
formation were seen in the group diagnosed by clinical 
definition. Chest X-ray was performed on all patients, and 
23 (47.9%) had evidence of active or old pulmonary TB. 
Thirteen patients had active pulmonary TB (including 
11 microbiologically-confirmed and 2 miliary TB without 
microbiological confirmation), while 10 patients had old 
pulmonary TB lesions.
Treatment and outcome
Of the 48 patients, 18 (37.5%) received anti-TB therapy 
alone, and 30 patients (62.5%) had combined medical 
treatment and surgical intervention. Two patients (4.2%) 
were lost to follow-up before treatment was completed 
and one (2.1%) was still on treatment when this study was 
completed. Ten patients (22.2%) died, including eight 
who died before completion of treatment and two after 
completion of treatment. Of the 10 fatal cases, two were 
associated with TB. The mean treatment duration for 
the 37 patients (excluding the 2 patients who were lost to 
follow-up, the 1 patient still on treatment, and those 8 
patients who died before completion of treatment) was 
11.4 ± 3.7 months. The clinical characteristics of patients 
treated medically versus those treated by combined medi-
cal and surgical methods are shown in Table 3. Patients 
that had combined medical and surgical treatment had 
suffered symptoms for a longer period prior to diagnosis 
(8.19 ± 6.68 months vs. 4.78 ± 3.85 months; p = 0.030), and 
also tended to have more favorable outcomes (82.6% vs. 
50.0%; OR = 4.750; 95% CI = 1.056–21.360; p = 0.063).
At the end of anti-TB therapy, 10 patients had been on 
a short-course treatment and 27 on a long-course treat-
ment. There were no significant differences in the age, sex, 
duration of symptoms prior to diagnosis, underlying dis-
eases, clinical features, laboratory data on admission, con-
comitant pulmonary TB, image findings and favorable 
outcomes between these two groups.
At the end of follow-up period, the outcome for 37 
patients were evaluated (Table 4). Twenty-six patients had 
a favorable outcome and 11 had an unfavorable outcome. 
The patients with an unfavorable outcome were older 
(72.73 ± 5.24 years vs. 57.77 ± 17.13 years; p < 0.001), suf-
fered more limb weakness (100% vs. 42.3%; p = 0.001), and 
incontinence (45.5% vs. 0%; p = 0.001), and had image find-
ings of spinal kyphotic deformity (81.8% vs. 30.8%; OR = 
0.099, 95% CI = 0.017–0.565; p = 0.013) and spinal cord 
compression (72.7% vs. 15.4%; OR = 0.068, 95% CI = 0.012–
0.374; p = 0.001).
Discussion
In this retrospective study, factors including older age, 
limb weakness and incontinence, along with image find-
ings of spinal kyphotic deformity and evidence of spinal 
cord compression on diagnosis, were significantly associ-
ated with an unfavorable outcome for spinal TB. Patients 
suffering symptoms for a longer period prior to diagnosis 
tended to require surgery. Surgery was related to a favorable 
outcome. Out results also show that a longer period of anti-
TB treatment (> 9 months) did not improve the outcome.
The 48 patients with spinal TB constituted 1.2% of 
all cases of TB in our study. The proportion of spinal TB 
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relative to the total number of TB cases was 0.5–5.4% in 
some of the larger studies.1,6,7,24,25 However, the exact inci-
dence of spinal TB is still unknown.1,7 In developing coun-
tries, spinal TB occurs in older children and young adults, 
especially in poverty associated regions; but in developed 
countries it has become a disease of older patients.26,27 
The mean age in our study was 64 years, which is higher 
than in other studies (range, 35–53 years).1,3,7,10,24,28 Older 
Table 3. Clinical characteristics of patients with spinal tuberculosis: medical treatment versus combined medical and surgical 
treatmenta
 
Medical treatment
 Combined medical  
Variable  and surgical OR (95% CI) pb
 
only (n = 18)
 treatment (n = 30)
Age (yr) 68.11 ± 13.60 62.03 ± 16.27 – 0.190
Sex, male:female 10:8 14:16 0.700 (0.216–2.265) 0.766
Duration of symptoms 4.78 ± 3.85 8.19 ± 6.68 – 0.030
to diagnosis (mo)
Symptoms
 Back pain 17 (94.4) 29 (96.7) 1.706 (0.100–29.073) 1.000
 Neurological deficits 14 (77.8) 23 (76.7) 0.939 (0.232–3.794) 1.000
  Limb weakness 12 (66.7) 18 (60.0) 0.750 (0.221–2.546) 0.878
  Limb numbness  8 (44.4) 19 (63.3) 2.159 (0.657–7.096) 0.329
  Incontinence  4 (22.2)  3 (10.0) 0.389 (0.076–1.985) 0.400
 Fever  9 (50.0) 10 (33.3) 0.500 (0.151–1.653) 0.402
Laboratory finding on admission
 WBC (× 109/L) 8.894 ± 6.020 7.494 ± 1.950 – 0.350
 CRP (mg/L) 78.42 ± 95.88 41.43 ± 42.38 – 0.136
 ESR (mm/hr) 80.56 ± 43.04 66.95 ± 26.46 – 0.400
Location of spinal TB
 Cervical 1 (5.6) 1 (3.3) 0.586 (0.034–9.991) 1.000
 Thoracic  7 (38.9)  9 (30.0) 0.673 (0.197–2.299) 0.752
 Thoracolumbar  2 (11.1)  6 (20.0) 2.000 (0.358–11.178) 0.692
 Lumbar  8 (44.4) 12 (40.0) 0.833 (0.255–2.718) 1.000
 Lumbosacral 0 (0.0) 2 (6.7) – 0.521
Image findings
 Abscess formation 12 (66.7) 25 (83.3) 2.500 (0.634–9.858) 0.288
 Spinal kyphotic deformity  6 (33.3) 16 (53.3) 2.286 (0.679–7.699) 0.295
 Collapse vertebra 12 (66.7) 21 (70.0) 1.167 (0.333–4.084) 1.000
 Spinal cord compression  7 (38.9) 11 (36.7) 0.910 (0.273–3.032) 1.000
 Number of vertebra 2.22 ± 0.43 2.60 ± 1.30 – 0.152
Concomitant pulmonary TB  3 (16.7)  8 (26.7) 1.818 (0.414–7.990) 0.499
Duration of treatment (mo) 12.53 ± 3.03 10.76 ± 3.98 – 0.173
Long course treatment  11 (84.6) 16 (66.7) 0.364 (0.065–2.050) 0.440
Favorable outcome  7 (50.0) 19 (82.6) 4.750 (1.056–21.360) 0.063
aData presented as n (%), mean ± standard deviation or odds ratio (95% confidence interval); bFisher’s exact test or χ2 test for categorical 
variables and Student’s t test for continuous variables. CI = Confidence interval; CRP = C-reactive protein; ESR = erythrocyte sedimentation 
rate; OR = odds ratio; TB = tuberculosis; WBC = white blood cell count.
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age is a factor related to an unfavorable outcome, which 
confirms the findings reported in previous studies.7,13 
Early diagnosis of spinal TB in the elderly is difficult. This 
is because they often have some degree of back pain due 
to degenerative changes or osteoporosis of the spine that 
leads to compression fracture, and the back pain may 
pres ent for months or even years, causing a delay in diag-
nosing the spinal TB that may result in an unfavorable 
Table 4. Clinical outcome for patients with spinal tuberculosis (n = 37)a
Variable Unfavorable (n = 11) Favorable (n = 26) OR (95% CI) p
Age (yr) 72.73 ± 5.24 57.77 ± 17.13 – < 0.001
Sex, male:female 5:6 14:12 1.400 (0.340–5.765) 0.915
Duration of symptoms to 7.79 ± 7.38 7.50 ± 6.18 – 0.904
diagnosis (mo)
Symptoms
 Back pain 10 (90.9) 25 (96.2) 2.500 (0.142–43.968) 0.512
 Neurological deficits 11 (100.0) 18 (69.2) – 0.076
  Limb weakness 11 (100.0) 11 (42.3) – 0.001
  Limb numbness 8 (72.7) 14 (53.8) 0.438 (0.094–2.030) 0.466
  Incontinence 5 (45.5) 0 (0) – 0.001
 Fever 6 (54.5) 7 (26.9) 0.307 (0.071–1.335) 0.143
Laboratory findings on admission
 WBC (× 109/L) 7.469 ± 2.663 7.726 ± 2.073 – 0.753
 CRP (mg/L) 73.83 ± 97.66 44.83 ± 51.34 – 0.243
 ESR (mm/hr) 52.60 ± 31.86 74.57 ± 33.26 – 0.218
Location
 Cervical  0 (0.0) 1 (3.8) – 1.000
 Thoracic 5 (45.5)  7 (26.9) 0.442 (0.102–1.922) 0.443
 Thoracolumbar 4 (36.4) 2 (7.7) 0.146 (0.022–0.970) 0.051
 Lumbar 2 (18.2) 14 (53.8) 5.250 (0.945–29.180) 0.071
 Lumbosacral 0 (0) 2 (7.7) – 1.000
Image findings
 Abscess formation 8 (72.7) 19 (73.1) 1.018 (0.209–4.965) 1.000
 Spinal kyphotic deformity 9 (81.8) 8 (30.8) 0.099 (0.017–0.565) 0.013
 Collapse vertebra 10 (90.9) 16 (61.5) 0.160 (0.018–1.447) 0.119
 Cord compression 8 (72.7)  4 (15.4) 0.068 (0.012–0.374) 0.001
 Number of vertebra 2.73 ± 0.79 2.27 ± 1.08 – 0.213
Concomitant pulmonary TB 2 (18.2)  6 (23.1) 1.350 (0.227–8.031) 1.000
Duration of treatment (mo) 11.13 ± 2.88 11.41 ± 4.16 – 0.852
Combined medical and 4 (36.4) 19 (73.1) 4.750 (1.056–21.360) 0.063
surgical treatment
Long course treatment 7 (77.8) 18 (69.2) 0.643 (0.109–3.806) 1.000
aData presented as n (%), mean ± standard deviation or odds ratio (95% confidence interval). OR = Odds ratio; CI = Confidence interval; 
CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; TB = tuberculosis; WBC = white blood cell count.
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outcome.27 In our study, patients aged over 60 years suf-
fered from greater levels of neurological deficit and limb 
weakness. Clinicians should be alert to the possibility of 
spinal TB when elderly patients present with chronic back 
pain and neurologic deficits in combination with a raised 
erythrocyte sedimentation rate and C-reactive protein lev-
els, which suggest that spinal pain is due to inflammation. 
Suitable diagnostic tools must be initiated.
In cases of musculoskeletal TB, active lung infection 
was present in 30–36% of patients.5 In spinal TB with con-
comitant active pulmonary TB, the reported rate was 10–
28%.3,10,11,26,29 Eleven of our patients (22.9%) had evidence 
of active pulmonary TB based on a positive sputum AFB 
smear and culture. Moreover, 23 patients (47.9%) had ac-
tive, or old, pulmonary TB on chest radiographs. Spinal 
TB should be considered in patients with spinal abnor-
malities and a history of old, or active, pulmonary TB. 
Thus routine examination for mycobacteria in sputum 
and chest radiography should be performed when spinal 
TB is suspected.
The most common presenting symptoms of spinal TB 
in our study were back pain, neurological deficits and 
fever. In our study and others, 90–100% of patients had 
back pain.7,22,25,28 Fever is not common, with a reported 
rate of 31–45%.1,7,11,24,27 In our study, 39.6% of patients 
had fever. Neurological involvement in spinal TB has been 
reported in 23–76% of patients, with differences in sever-
ity.1,3,7,10,11,24,30 Neurological deficits were more common 
in our study, and limb weakness and incontinence were 
significantly related to an unfavorable outcome. The 
mean duration of symptoms prior to diagnosis is from 
3 to 6 months.1,7,27 Longer duration of symptoms prior to 
diagnosis may contribute to progression of the vertebral 
lesion and often results in the appearance of neurological 
deficits.1
TB is generally curable with chemotherapy, and it still 
remains to be determined whether there is a need for sur-
gical intervention in spinal TB. Owing to the additional 
problems encountered in spinal TB, namely, kyphotic 
angle and neurological deficit,14 surgical intervention has 
been suggested by several studies. The indications are: (1) 
neurological deficit caused by spinal cord compression; 
(2) spinal instability caused by vertebral collapse, vertebral 
destruction, or a kyphotic angle of > 30° (or a progressive 
angle); (3) no response to, or failure of, anti-TB therapy; 
(4) large paraspinal abscess; and (5) non-diagnostic 
biopsy.8,11,20,21,30,31 A Cochrane review of randomized con-
trolled trials regarding the use of routine surgery in addition 
to chemotherapy for spinal TB concluded that there was 
no significant benefit from the routine use of surgery.14 
However, in our study, univariate analysis suggests a trend 
towards favorable outcomes after combined medical and 
surgical treatment. The proportion of patients who re-
ceived surgery varies from 20.0% to 70.5%.1,3,7,24,32 A rela-
tively higher surgical rate (62.5%) was observe in our study, 
possibly due to the fact that there was a high percentage 
of patients with a neurological deficit (77.1%). Another 
problem is raised regarding the kyphotic angle. An angle 
> 30° is considered as progressive in several studies.8,33 
When patients have initial imaging results suggesting a 
kyphosis, the kyphotic angle should be measured and reg-
ularly followed up. Although the kyphotic angle was not 
measured in our study, kyphotic deformity was associated 
with an unfavorable outcome. Surgical correction may be 
considered for large or progressive deformities.20,33
A high sensitivity and specificity in the early diagnosis 
of spinal TB can be achieved using both CT and MRI 
scans1,10 because early findings may not be visible on plain 
radiography for up to 8 weeks.4,24 As image findings 
are not fully reliable for differentiating spinal TB from 
other infections or neoplasms, bacteriologic or histo-
logic confirmation must be performed.7,10 CT-guided 
fine-needle aspiration is a useful method for confirming 
histopathological and microbiological studies.10,34 In pre-
vious studies, the yields of CT-guided fine-needle aspira-
tion for positive AFB smear, culture, and granulomas 
were 35–52%, 57–83%, and 70–90%, respectively.7,10,24 We 
showed comparable results for the diagnostic yields of 
microbiological tests. However, discrepancies in the diag-
nostic yields obtained from histopathological results may 
be due to the accessibility of the lesion, the operator’s 
technique and experience, and the number of microbacte-
ria and multinucleated giant cells in the specimen.35 
Previous studies found no significant differences between 
the yields of CT-guided fine-needle aspiration and open 
surgery.24,35 If surgery is not immediately indicated in pa-
tients with a suspicion of spinal TB from clinical features 
and image findings, CT-guided fine-needle aspiration is a 
safe, fast, reliable and relatively inexpensive diagnostic 
procedure.
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The duration of anti-TB therapy remains controver-
sial.13 MRC studies showed that a 6-month regimen for 
spinal TB, when combined with surgery, is as effective as a 
9-month regimen.17,19,29 Support for the MRC recommen-
dations was provided by a recent literature review.15 In 
contrast to the MRC recommendations and ATS guide-
lines, a somewhat longer course of therapy for spinal TB 
was administered in some studies.24,25,27,30 A small retro-
spective study found an alarming rate of relapse with the 
6-month regimen and they suggested that treatment 
should be continued for at least 9 months.36 In our study, 
there was no significant difference between short- or 
long-course anti-TB therapy in terms of outcome.
There are several limitations in this study. First, it 
was a retrospective study and the sample size was small. 
Second, we enrolled cases not diagnosed by microbiology 
and histopathology, although such cases were also en-
rolled in other studies.13,24 If these probable cases are ex-
cluded, factors including older age, neurological deficit, 
and image findings of spinal cord compression are signif-
icantly associated with an unfavorable outcome in those 
patients with a definite diagnosis of spinal TB.
In conclusion, we suggest that spinal TB should be 
considered as a differential diagnosis in elderly patients 
with chronic back pain and neurologic deficit, which are 
both associated with unfavorable outcomes. Aggressive 
diagnosis of spinal TB is necessary, and CT-guided fine-
needle aspiration may be a reliable and less invasive 
method than open surgical biopsy for the diagnosis of 
spinal TB. The duration of anti-TB therapy may only need 
to be 9 months. Combined surgical intervention and 
medical treatment tended to result in a more favorable 
outcome, especially for patients with advanced disease, in-
cluding progressive kyphotic deformity and/or neurological 
deficit.
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